Search Results for: POD

DSCSA, EDDS, EPCIS

Drug Supply Chain Security Act, Phase II: Here’s what you MUST know

As 2020 transitioned to 2021, we took another step closer toward the implementation of 2023 Drug Supply Chain Security Act, Phase II. From manufacturers to wholesalers, pharmacies and other stakeholders, many uncertainties are swirling around the subject, so today we are writing to try to dispel some of the concern. Let’s start with an overview … Continue reading Drug Supply Chain Security Act, Phase II: Here’s what you MUST know →

Russia

Mixed Signals From Russia

I’m not talking about the mixed signals from Russia in your daily political newsfeed, I’m talking about the mixed signals we see between the Russian Federation decrees for their pharma serialization and traceability mandate, and the announcements of the government’s designated technology contractor to develop that system:  CRPT, LLC.  Considering how short the deadlines are, … Continue reading Mixed Signals From Russia →

Product Identifier Authentication, Saleable Returns Verification

DSCSA: Saleable Returns Verification

The Healthcare Distribution Alliance (HDA) Traceability Seminar that was held back in early November was so packed with valuable information that I still have a number of topics queued up from that event for RxTrace essays in the future.  Today I want to take a closer look at the results of the Saleable Returns Pilots … Continue reading DSCSA: Saleable Returns Verification →

Anti-counterfeiting

Sponsored: Will Global Serialization Mandates Result In Less Counterfeiting?

One of the focuses of RxTrace is to explore global pharma serialization and tracing regulations in an attempt to discover some of their implications.  Some implications turn out to be obvious, but some turn out to be surprising.  Identifying the implications early provides us with a better understanding of what to expect from our investments … Continue reading Sponsored: Will Global Serialization Mandates Result In Less Counterfeiting? →

EU FMD

EU FMD: Aggregation Is Not Mandated, But It Will Be Necessary

3 Comments

Ever since the E.U. Falsified Medicines Directive (FMD) was passed in 2011 my European friends have touted the fact that their government mandated solution would take a “bookend” approach.  The implication was always that it would be much less complex than the ePedigree approaches that were being planned by various U.S. states, and then by … Continue reading EU FMD: Aggregation Is Not Mandated, But It Will Be Necessary →

DSCSA, HDMA

HDMA DMC Serves Sizzling Steak With A Small Side Of Snake Oil

According to the HDMA, their Distribution Management Conference and Expo in San Antonio last week broke the attendance record at more than 500 attendees, but for the life of me, I can’t figure out why the number wasn’t double that amount.  When you compare the value you receive by attending this (or any) HDMA event with … Continue reading HDMA DMC Serves Sizzling Steak With A Small Side Of Snake Oil →